Clinical Manual of Neuropsychiatry focuses on the assessment, diagnosis, and treatment of the full spectrum of neuropsychiatric disorders, as well as those conditions that have significant neuropsychiatric components. With the help of this highly practical manual, clinicians are empowered to evaluate patients and treat the neuropsychiatric aspects of a host of disorders. The manual: Sets forth a concise, step-by-step approach to assessing patients, by beginning with the indications for a neuropsychological evaluation, and progressing through the patient interview, physical examination, and measures that are useful diagnostic indicators, such as psychological testing and structural and functional neuroimaging. Offers complete physiological and epidemiological information about each condition, by providing much-needed context and helping the clinician to identify the focal neurological symptoms to look for, potential contributing factors, and the course a disease is likely to follow. Covers the general neuropsychiatric and neuropsychological considerations the clinician must take into account when attempting to understand the factors that influence presenting symptoms and behavioral changes. For example, intracranial pressure can be and elusive consequence of central nervous system (CNS) tumors and has been implicated in behavior changes such as apathy and depression. Aids the clinician in making a clinical diagnosis through the precise evaluation of a patient's neurological and psychiatric signs and symptoms, through taking a careful history, and through a directed physical examination the patient. Addresses the full range of available treatment options, including psychopharmacological, psychotherapeutic, and cognitive rehabilitation modalities. Presents an utterly up-to-date chapter on psychopharmacological treatment of patients with neuropsychiatric disorders, and includes an abundance of tables that compare indications, efficacy, and side effect profiles for the full range of drugs that are likely to be prescribed. While acknowledging the ongoing dialogue on the nature of neuropsychiatry, Clinical Manual of Neuropsychiatry focuses on the paramount duty of the physician, whether psychiatrist or neurologist: to understand each patient's underlying disease and to ease the suffering it causes. This meticulously referenced, thoughtfully illustrated, and elegantly structured volume deserves a place in both the beginning and seasoned clinician's library.
The second book in the Evidence-Based Guides series, The Evidence-Based Guide to Antidepressant Medications, provides a clear reference to the current knowledge and evidence base for the use of antidepressants among a variety of patients across a wide range of disorders. Chapters within this guide are authored by experts in their respective areas of practice, and synthesize a large amount of medical literature into a comprehensive, yet understandable, concise, reader-friendly guide. Each chapter covers both the FDA-approved and off-label use of antidepressant medications and the evidence base for their use. Each chapter also features useful tables pertaining to specific topics, such as summaries of uses and efficacy, and important clinical pearls of wisdom in the Key Clinical Concepts. Topics covered in chapters within this text include: Use of selective serotonin reuptake inhibitors, MAOIs, and tricyclic antidepressants in major depressive disorder, bipolar depression, psychotic depression, and treatment-resistant depression. Acute management of anxiety disorders, obsessive-compulsive disorder, and specific phobias through antidepressant use. Use of antidepressant medication in medically ill patients, such as those with cardiovascular, pulmonary, gastrointestinal, renal, and endocrine diseases, as well as cancer, chronic pain, HIV, burns and hospital-based trauma.Developmental considerations necessary to keep in mind when prescribing antidepressants to children and adolescents, along with an outline of controlled studies and their special attention to safety. Medication management in geriatric patients, including antidepressant use among depressed elderly patients with dementia, stroke, or Parkinson's disease. Risks and benefits of prescribing antidepressants during pregnancy and lactation. Together, the authors have synthesized a large amount of medical literature into a comprehensive, yet understandable, concise, reader-friendly guide. The Evidence-Based Guide to Antidepressant Medications is a must-have reference for psychiatrists and other practicing clinicians, residents in training, psychiatric nurses, social workers and researchers.
The second edition of this groundbreaking text represents a complete departure from the structure and format of its predecessor. Though still exhaustive in scope and designed to provide a knowledge base for a broad audience – from the beginning student to the seasoned analyst or academician – this revision emphasizes the interdisciplinary nature of psychoanalytic thought and boldly focuses on current American psychoanalysis in all its conceptual and clinical diversity. This approach reflects the perspective of the two new co-editors, whose backgrounds in linguistics and social anthropology inform and enrich their clinical practice, and the six new section editors, who themselves reflect the diversity of backgrounds and thinking in contemporary American psychoanalysis. The book begins with Freud and his circle, and the origins of psychoanalysis, and goes on to explore its development in the post-Freud era. This general introduction orients the reader and helps to contextualize the six sections that follow. The most important tenets of psychoanalysis are defined and described in the «Core Concepts» section, including theories of motivation, unconscious processes, transference and countertransference, defense and resistance, and gender and sexuality). These eight chapters constitute an excellent introduction to the field of psychoanalysis. The «Schools of Thought» section features chapters on the most influential theories – from object relations to self psychology, to attachment theory and relational psychoanalysis, and includes the contributions of Klein and Bion and of Lacan. Rather than making developmental theory a separate section, as in the last edition, developmental themes now permeate the «Schools of Thought» section and illuminate other theories and topics throughout the edition. Taking a more clinical turn, the «Treatment and Technique» section addresses critical subjects such as transference and countertransference; theories of therapeutic action; process, interpretation, and resistance, termination and reanalysis; combined psychoanalysis and psychopharmacotherapy, child analysis, ethics, and the relationship between psychoanalysis and psychodynamic psychotherapy. A substantive, utterly current, and meticulously referenced section on «Research» provides an in-depth discussion of outcome, process, and developmental research. The section entitled «Psychoanalysis and Other Disciplines» takes the reader on a fascinating tour through the many fields that psychoanalysis has enriched and been enriched by, including the neurosciences, philosophy, anthropology, race/ethnicity, literature, visual arts, film, and music. A comprehensive Glossary completes this indispensable text. The Textbook of Psychoanalysis is the only comprehensive textbook of psychoanalysis available in the United States. This masterful revision will both instruct and engage those who are learning psychoanalysis, those who practice it, and those who apply its theories to related disciplines. Though always controversial, this model of the human psyche still provides the best and most comprehensive insight into human nature.
While the APA's Textbook of Addiction Psychiatry covers material that a general psychiatrist or primary care physician needs for the appropriate referral and initial management of stimulant dependence, Cocaine and Methamphetamine Dependence: Advances in Treatment goes beyond this basic knowledge and addresses the rapid evolution of both the understanding and the treatment of stimulant abusers. It also sheds light on how the epidemiology of cocaine, amphetamine and methamphetamine abuse and dependence have substantial differences in geographic distribution both here and abroad, and how treatments are evolving to help these complex patients benefit from emerging pharmacological and behavioral therapies. Cocaine dependence complications account for one out of every three drug-related emergency room visits. Coroners' reports relate stimulants to the direct cause of death in 25% of cocaine overdoses and 68% of methamphetamine overdoses or as antecedents causing cardiovascular or medical problems leading to death in 20% of these abusers. Additionally, cocaine and methamphetamine abuse and dependence frequently co-occur with other major mental illnesses such as schizophrenia, major depression, and posttraumatic stress disorder. This makes a greater understanding of stimulant dependence among the psychiatric community an integral part of providing effective evaluation and treatment. Cocaine and Methamphetamine Dependence provides: An introduction of the DSM-5 plan to drop the distinction between abuse and dependence and add craving as a criterion. An overview of how the epidemiology of stimulant abuse is changing and pharmaceutical abuse is rising due to factors such as greater availability through family and friends who are increasingly being prescribed stimulants for conditions like weight loss or attention deficit disorder. The insight that even after long abstinence, stimulant users may remain vulnerable to amphetamine-induced psychosis, with delusions, paranoia and compulsive behavior. The insight that a comprehensive assessment of the patient involves the management of aberrant behaviors such as intoxication, violence, suicide, impaired cognitive function, and uncontrolled affective displays. A focus on treatment, emphasizing that the most important component of stimulant treatment involves behavioral therapies, often in combination with adjunctive medications. A review of the criminal justice system's shift away from punitive action and towards more human treatment, including the far-reaching benefits of medical management and treatment. Fortunately, our understanding of stimulant abuse and dependence is growing at a time when a steady stream of new users and casualties is still accumulating. Constant vigilance regarding changes in epidemiology, fluctuations in drug availability, and changes in drug trafficking patterns are essential to recognition of new drug abuse patterns and their identification and treatment. Cocaine and Methamphetamine Dependence should be on the bookshelf of residents, physicians and psychiatrists who are highly likely to come into contact with one of the millions using and abusing stimulants today.
In Women in Psychiatry, 21 accomplished women psychiatrists in private practice, teaching institutions, hospitals, public health treatment programs, and leadership positions reveal both the challenges and rewards of being in a wide array of professional positions. The stories are heartfelt and personal as well as professional accounts of obstacles overcome and milestones achieved. In a field once completely dominated by men, nearly one-third of physicians who identified themselves as practicing psychiatry in the U.S. were women, and the diversity of their approaches to the practice of psychiatry is encouragingly illustrated in this book. Women in Psychiatry clearly demonstrates where an interest in science or medicine can lead when combined with determination, guidance, experience, mentoring, perseverance, and organizational support. The featured women represent diverse backgrounds, ethnicities, positions, career pathways, and accomplishments. All the authors share lessons learned and provide recommendations on what they found helpful in achieving their goals of personal and professional fulfillment. These chapters present many common themes among women professionals both within and outside of psychiatry, including handling pregnancy and motherhood while building a career, the potential strain between women and men in the field, and some of the income and leadership role inequities that still exist. Features and benefits of Women in Psychiatry include: Insights into career paths through descriptions of pivotal events and decisions that shaped their careers as scientists. Perspectives and advice on how to balance personal and professional responsibilities, both in training and in practice. Illustrations of the role played by cultural and linguistic background, race, ethnicity, sexual orientation, religion, marital status, subspecialty, place of employment, and work setting. The importance of mentorship throughout the process, first as a recipient and ultimately as a mentor to other women entering the field. Strategies these authors used to accomplish goals and the various styles of leadership that helped them reach those goals. The historical context for understanding that until recent decades, despite irrefutable evidence that women in the biomedical professions are capable, there were few in most fields with the exception of nursing, dental hygiene, and elementary science teaching. Women in Psychiatry is the ideal book for women who are considering a career in psychiatry or other areas of medicine. It is also a book for partners and spouses of women in medicine and psychiatry. It is an inspirational and educational document that women and men, whether in medicine or other, nonrelated careers, can value and appreciate through the recounting of personal and professional experiences that made a difference.
Psychiatry Review and Canadian Certification Exam Preparation Guide is the first exam preparation text intended specifically for candidates taking the Royal College of Physicians and Surgeons of Canada (RCPSC) psychiatry examination. This concise, single volume review contains «Canadian-specific» content so that readers need not modify other sources, but may rely on it as their primary source of preparation.The volume is based on The American Psychiatric Publishing Board Review Guide for Psychiatry and cites only validated sources used in other APP books, so candidates can be assured of its content integrity. It has been fully updated, and it includes a multitude of features that will appeal to harried candidates: The information presented is consistent with Canadian psychiatry practice. References have been drawn from the Canadian psychiatric literature, and laboratory units; medication names and doses, and the language employed are consistent with Canadian medicine and psychiatry; The volume is organized according to familiar DSM-IV classifications, allowing readers to quickly locate the most appropriate chapter. It does not neglect foundational knowledge, however, offering complete coverage of basic neuroanatomy as well as more advanced topics such as neuroimaging, psychopharmacology, and the cultural and legal aspects of psychiatric illness; Quick-reference tables summarizing diagnostic criteria for specific psychiatric disorders and other critical information are especially useful and abundant; and A rigorous 200-question practice exam and answer guide provide a reality check for prospective exam takers. The exam's structure reflects the actual board examination, with question topics commingled, and candidates seeking additional questions and annotated answers to enhance their preparation are referred to additional online self-assessments. The Psychiatry Review and Canadian Certification Exam Preparation Guide represents the best of psychiatric scholarship, combined with insight into the RCPSC psychiatry exam, and a keen eye for presenting the necessary information in a logical, easy-to-remember manner. This one-stop resource is destined to become candidates' constant companion in the months leading up to the exam, and after.
Even in today's more enlightened society, it takes courage for many lesbian, gay, bisexual, and transgender (LGBT) individuals to «come out of the closet» and embrace their sexual orientation and identity. Coming out, or facing internal and societal conflicts related to sexuality, involves a great deal of anxiety that can permeate other aspects of an LGBT individual's life – particularly when seeking psychiatric treatment. The goal of The LGBT Casebook is to help clinicians, trainees, and other mental health professionals address the mental health needs of LGBT people in the context of problems these individuals face in their everyday lives, including homophobia and discrimination.The LGBT Casebook begins with five chapters devoted to basic concerns that affect LGBT populations, including coming out, heterosexist attitudes, the «don't ask, don't tell» mentality, legal issues, gay parenting, and sexual identity in patient-therapist relationships. In the rest of the book, clinician-authors present case studies of 20 patients with different DSM diagnoses, illuminating the impact of LGBT identity and illustrating a way of working with each presented patient. Features and benefits of The LGBT Casebook include: Insights into the unique problems LGBT people face in their everyday lives when compared with heterosexual individuals. Problems that are common to all LGBT individuals, such as the anxiety of being in the closet (hiding one's identity) or coming out (embracing one's identity). Practitioners with little experience in working with the LGBT population can gain a better understanding of psychiatric diagnoses within the context of an LGBT individual's everyday life. The book can be read cover-to-cover to gain insights into the full diversity of the LGBT population, or by specific chapters of interest to help with the diagnosis of a patient currently in treatment. A glossary at the back of the book defines both clinical and colloquial terms and phrases that clinicians and patients use to define themselves and their peers. While The LGBT Casebook is the ideal general overview and roadmap for the clinician new to treating LGBT patients, it also provides new pearls of wisdom and insights for psychiatrists, residents, medical students, nurses, and clinical social workers who are already familiar with working with the LGBT community. By introducing a diverse range of people, diagnoses, and presenting problems, it will serve as a valuable reference book for all mental health professionals when assessing and treating the mental health concerns of lesbian, gay, bisexual, and transgender patients.
The American Board of Psychiatry and Neurology: Looking Back and Moving Ahead honors the 75th anniversary of the ABPN by reviewing the Board's history and evolution, describing the subspecialties and the role that certification plays in their practice, explaining the current status of the ABPN's programs, and exploring future directions. A substantive contribution to our understanding of the historical and contemporary issues that confront the Board, the profession, and the community of practitioners, this book Provides in-depth chapters on the neurological subspecialties, including child neurology, clinical neurophysiology, vascular neurology, neuromuscular medicine, and neurodevelopmental disabilities. Explores the psychiatric subspecialties in detailed chapters on addiction psychiatry, child and adolescent psychiatry, geriatric psychiatry, psychosomatic medicine, and forensic psychiatry. Describes the evolution and ongoing management of the credentialing process, including exam development, administration, and scoring. Addresses the critical importance of ethical standards and their integral role in certification, licensing, and practice. Discusses the future of board certification and the importance of recertification and lifelong learning. With chapters written primarily by current or former ABPN directors or senior staff members, The American Board of Psychiatry and Neurology: Looking Back and Moving Ahead will be invaluable to candidates, training programs, and institutions preparing for certification; diplomates seeking to maintain certification; and subspecialists desiring to understand the role of certification in their subspecialty.
As many as 35-40% of patients afflicted with Major Depressive Disorder (MDD) are treatment resistant, a situation that places a massive emotional and financial burden on society and challenges the mental health profession to develop new treatment paradigms and practices. Even the most astute clinicians can be frustrated when treatment options fail to be effective or work for only a brief time, leaving them to wonder what course to pursue next. Treatment Resistant Depression: A Roadmap for Effective Care gives clinicians and their patients what they need most desperately: a sequence of steps that reflect state-of-the-art diagnostic procedures and integrates all evidence-based treatment modalities – in short, a roadmap to wellness and recovery.Based primarily on the experiences of the authors, all of whom are leading researchers and/or clinicians in Treatment Resistant Depression and affiliated with the University of Michigan Comprehensive Depression Center, the book also draws upon the clinical research advances and treatment innovations of programs around the world. Although the book's step-by-step organization is clear and easy to follow, its coverage, scope, and level of sophistication are anything but simplified. This book Is comprehensive, addressing treatment options, including psychopharmacotherapy, psychotherapy, neuromodulation (ECT, transcranial magnetic stimulation, deep brain stimulation, vagus nerve stimulation), exercise, nutrition, self-management approaches to enhance adherence, behavioral sleep programs, and others Addresses treatment resistant depression across the lifespan, reflecting the diverse demographics of depression, which knows no age, gender, or socioeconomic status Emphasizes the authors' commitment to early intervention and provides techniques for identifying young people who are at risk for developing depression or already expressing symptoms of the disease Recognizes the chronicity of depression, rather than focusing on only the acute stage, and in this way allows for more effective treatment over the patient's lifetime Introduces self-management as playing a critical role in the patient's prognosis, engagement, adherence to clinical steps that help maintain recovery, and self-esteem Promotes the development of new, personalized, and predictive biomarkers to target treatment more effectively. Designed to be useful across disciplines and treatment modalities, the book includes a multitude of tables, graphs, and learning aids that will benefit students, instructors, and clinicians. At the same time, the book promises to be a valuable resource for patients and their families, since Treatment Resistant Depression is both difficult to live with and little understood. No other book offers so much practical guidance, sound research and hope.
With a new foreword by Nora Volkow, Director of the National Institute on Drug Abuse, this second edition of Office-Based Buprenorphine Treatment of Opioid Use Disorder provides updated information on evidence-based treatment for opioid use disorder (OUD) – an increasingly important topic as the epidemic of opioid misuse and overdose deaths grows in the United States.Bulleted clinical pearls at the end of each chapter, as well as specific clinical recommendations and detailed case discussions throughout, make it easier for readers to retain knowledge and integrate it into their clinical practice. The guide also features sample documentation and scales, including a treatment contract and a patient consent, that can be used to model documents in practice.This new edition of Office-Based Buprenorphine Treatment has been updated to reflect DSM-5 language, and two additional chapters have been included: one that addresses other pharmacotherapies useful in treating OUD, including methadone and naltrexone, and another that discusses OUD treatment specifically with regard to women's health and pregnancy.Among the numerous other revisions included in the second edition are the following: Information about new formulations of buprenorphine A discussion of the Comprehensive Addiction and Recovery Act (CARA) Changes to induction and maintenance target doses and recommendations for home inductions Information on diversion control plans Advice for working with Alcoholics Anonymous and Narcotics Anonymous A discussion on integrating buprenorphine into residential and inpatient opioid treatment programs This edition can also be used to complete the 8 hours of qualifying training required for the buprenorphine waiver. By a thorough reading of the material covered in the chapters of this book and successful completion of the posttest, physicians can meet the buprenorphine waiver training requirement.Written in a jargon-free style that does not require expertise in substance use disorder treatment, Office-Based Buprenorphine Treatment of Opioid Use Disorder is an accessible, indispensable reference for primary care physicians, psychiatrists, nurse practitioners, residents, medical students, and anyone with an interest in learning about and prescribing buprenorphine.